Doximity Inc Cl A (DOCS) Stock Price, Quote & News

Company Profile

Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants...

Industry: Health Information Services

Sector: Healthcare

Phone: 650 549 4330

Website: www.doximity.com

Address:

500 3rd Street, Suite 510, San Francisco, United States

OnlyFibs Oct. 5 at 8:05 PM

$DOCS - Doximity - Bullish - Price just needs to close over $74.02 and I will take a long position - Simplicity #hovdid

0 · Reply

MoneyGroupLLC Oct. 3 at 6:37 PM

Enter: $DOCS NOV 21 2025 $72 CALLS Buy in Price: $5.70 - $5.75 Take Profit: $13.68 Stop Bleeding: $5.06 ROI Potential: 138% Exit Within: 126 Minutes https://moneygroup.us/alerts

0 · Reply

SweepCastApp Oct. 3 at 8:03 AM

$DOCS: Unusual Options Activity Alerted CALL flow observed 30x contracts at Strike price of $70 Exp on 02/20/2026 with Premium of $31K and showing BEARISH Sentiment

0 · Reply

jheerdink Oct. 2 at 7:44 PM

$TDOC Virtual Health Giant Teladoc Rallies On Thursday After Snapping Up Acquisitions in ’25 – ( $AMWL $DOCS $EVH ) https://vistapglobal.com/virtual-health-giant-teladoc-rallies-on-thursday-after-snapping-up-acquisitions-in-25-tdoc-amwl-docs-evh/

0 · Reply

lasoto3 Oct. 2 at 12:37 PM

$DOCS was looking at possible-entry but I don’t like that downgrade. Sidelines for now

0 · Reply

SweepCastApp Oct. 2 at 1:21 AM

$DOCS: Unusual Options Activity Alerted CALL flow observed 100x contracts at Strike price of $80 Exp on 02/20/2026 with Premium of $86K and showing BEARISH Sentiment

0 · Reply

WellHelloBears Oct. 1 at 7:26 PM

$DOCS goldman hit piece on what could have been a nice up day

1 · Reply

DARKP00L Oct. 1 at 6:08 PM

$DOCS 13:36 on Oct. 01 2025 Goldman Sachs Downgrades Doximity to Sell, Raises Price Target to $64 #tradeideas

0 · Reply

JarvisFlow Oct. 1 at 5:36 PM

Goldman Sachs has adjusted their stance on Doximity ( $DOCS ), setting the rating to Sell with a target price of 57 → 64.

0 · Reply

notreload_ai Oct. 1 at 11:13 AM

Goldman Sachs downgraded $DOCS to Sell from Neutral, setting a price target of $64, indicating a 13% downside potential due to slowing growth.

1 · Reply

Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation

Aug 8, 2025, 11:21 AM EDT - 2 months ago

Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings

Aug 7, 2025, 9:50 PM EDT - 2 months ago

Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript

Aug 7, 2025, 4:05 PM EDT - 2 months ago

Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers

Aug 7, 2025, 4:02 PM EDT - 2 months ago

Doximity Acquires Pathway, a Leader in AI Clinical Reference

Aug 7, 2025, 4:01 PM EDT - 2 months ago

Doximity Announces Fiscal 2026 First Quarter Financial Results

Jul 31, 2025, 5:00 AM EDT - 2 months ago

New Doximity Study Shows Modest Physician Pay Growth Amid Deeper Workforce Strain, Reimbursement Pressures

Jul 23, 2025, 3:35 PM EDT - 2 months ago

Doximity: Slowing Sales And EBITDA Growth

Jul 17, 2025, 4:01 PM EDT - 2 months ago

Doximity to Release Fiscal 2026 First Quarter Results on August 7, 2025

Jul 2, 2025, 10:36 AM EDT - 3 months ago

Doximity Crushes The Rule Of 40 - Try Rule Of 58

Jun 18, 2025, 7:18 AM EDT - 3 months ago

Doximity: A Unique, Debt-Free Healthcare-Tech Platform, Initiate With 'Buy'

May 21, 2025, 4:01 PM EDT - 4 months ago

Doximity to Present at the William Blair 45th Annual Growth Stock Conference

May 19, 2025, 7:47 AM EDT - 5 months ago

Doximity Stock 7.8% Higher After Key Trading Signal

May 16, 2025, 1:51 PM EDT - 5 months ago

These Analysts Cut Their Forecasts On Doximity After Q4 Results

May 16, 2025, 9:09 AM EDT - 5 months ago

Globant, Doximity, Applied Materials And Other Big Stocks Moving Lower In Friday's Pre-Market Session

AMAT GLOB

May 15, 2025, 8:35 PM EDT - 5 months ago

Doximity, Inc. (DOCS) Q4 2025 Earnings Call Transcript

May 15, 2025, 5:55 PM EDT - 5 months ago

Doximity Stock Drops 20% After Outlook Disappoints

May 15, 2025, 4:01 PM EDT - 5 months ago

Doximity Announces Fourth Quarter and Fiscal Year 2025 Financial Results

May 1, 2025, 9:23 AM EDT - 5 months ago

Doximity: Strong Fundamentals And Pharma Tailwinds Meet An Overpriced Valuation

Apr 24, 2025, 4:01 PM EDT - 5 months ago

Doximity to Release Fiscal 2025 Fourth Quarter and Full Year Results on May 15, 2025

Feb 21, 2025, 9:00 AM EST - 8 months ago

DOXIMITY INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.'s Directors and Officers for Breach of Fiduciary Duties – DOCS

Feb 14, 2025, 5:53 PM EST - 8 months ago

Doximity: Rating Downgrade As Near-Term Upside Is Priced In

Feb 14, 2025, 7:49 AM EST - 8 months ago

Doximity Momentum, Big Money Support Stays Strong

Feb 13, 2025, 4:29 PM EST - 8 months ago

Doximity to Participate in the Raymond James 46th Annual Institutional Investors Conference

Feb 10, 2025, 12:04 PM EST - 8 months ago

Doximity Q3 Earnings: Outpacing Even Management's Expectations

Feb 7, 2025, 1:24 PM EST - 8 months ago

Digital Health Platform Doximity Stock Jumps On Upbeat Annual Outlook, Analysts Raise Forecast

Feb 7, 2025, 10:38 AM EST - 8 months ago

Doximity shares pop 30% on revenue beat, rosy guidance

Feb 6, 2025, 8:01 PM EST - 8 months ago

Doximity, Inc. (DOCS) Q3 2025 Earnings Call Transcript

Feb 6, 2025, 5:14 PM EST - 8 months ago

Doximity shares soar 21% after company beats on revenue, raises fiscal year guidance

Feb 6, 2025, 4:02 PM EST - 8 months ago

Doximity Ranked #1 Best in KLAS Telehealth Video Platform for Fourth Consecutive Year

Feb 6, 2025, 4:01 PM EST - 8 months ago

Doximity Announces Fiscal 2025 Third Quarter Financial Results

Jan 16, 2025, 4:01 PM EST - 9 months ago

Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025

Jan 13, 2025, 6:51 AM EST - 9 months ago

Doximity: Upgraded To Buy Amid Promising Growth And Strong Execution

Jan 7, 2025, 8:00 AM EST - 9 months ago

Stock Picks From Seeking Alpha's December 2024 New Analysts

ALGM CE CEG ETD FDVV FSS HOG

Dec 24, 2024, 8:00 AM EST - 10 months ago

Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown

DXCM GDRX HIMS OSCR PGNY TDOC TEM

Dec 17, 2024, 8:00 AM EST - 10 months ago

Doximity Report Confirms That Telemedicine Serves Key Role in Modern Health Care

Dec 6, 2024, 7:52 AM EST - 10 months ago

Doximity: Strong Fundamentals And Growth Potential Makes It Attractive

Nov 15, 2024, 8:00 AM EST - 11 months ago

Doximity Q2 Earnings: Positioning Is Paying Off

Nov 8, 2024, 8:45 AM EST - 11 months ago

Why Doximity Stock is Set to Open at Highest Point in Over 2 Years Friday

Nov 8, 2024, 8:03 AM EST - 11 months ago

Doximity Stock Soars 42% Toward Best Day Ever. It's Not the Only Record.

Nov 7, 2024, 10:07 PM EST - 11 months ago

Doximity, Inc. (DOCS) Q2 2025 Earnings Call Transcript

Nov 7, 2024, 4:01 PM EST - 11 months ago

Doximity Announces Fiscal 2025 Second Quarter Financial Results

Oct 31, 2024, 4:01 PM EDT - 1 year ago

Doximity to Present at the Jefferies London Healthcare Conference

Oct 17, 2024, 4:01 PM EDT - 1 year ago

Doximity to Release Fiscal 2025 Second Quarter Results on November 7, 2024

Oct 15, 2024, 4:50 PM EDT - 1 year ago

Overlooked Stock: DOCS

Sep 24, 2024, 8:51 AM EDT - 1 year ago

Top 4 Health Care Stocks That May Keep You Up At Night

BFRG GILD GNFT

Aug 23, 2024, 5:29 AM EDT - 1 year ago

Reconsidering Doximity Shares: Should Investors Bet On A Sustained Revenue Growth Inflection

Aug 9, 2024, 11:47 PM EDT - 1 year ago

Doximity: Q1 Earnings Mark A Possible Turnaround For The Company (Rating Upgrade)

OnlyFibs Oct. 5 at 8:05 PM

$DOCS - Doximity - Bullish - Price just needs to close over $74.02 and I will take a long position - Simplicity #hovdid

0 · Reply

MoneyGroupLLC Oct. 3 at 6:37 PM

Enter: $DOCS NOV 21 2025 $72 CALLS Buy in Price: $5.70 - $5.75 Take Profit: $13.68 Stop Bleeding: $5.06 ROI Potential: 138% Exit Within: 126 Minutes https://moneygroup.us/alerts

0 · Reply

SweepCastApp Oct. 3 at 8:03 AM

$DOCS: Unusual Options Activity Alerted CALL flow observed 30x contracts at Strike price of $70 Exp on 02/20/2026 with Premium of $31K and showing BEARISH Sentiment

0 · Reply

jheerdink Oct. 2 at 7:44 PM

0 · Reply

lasoto3 Oct. 2 at 12:37 PM

$DOCS was looking at possible-entry but I don’t like that downgrade. Sidelines for now

0 · Reply

SweepCastApp Oct. 2 at 1:21 AM

$DOCS: Unusual Options Activity Alerted CALL flow observed 100x contracts at Strike price of $80 Exp on 02/20/2026 with Premium of $86K and showing BEARISH Sentiment

0 · Reply

WellHelloBears Oct. 1 at 7:26 PM

$DOCS goldman hit piece on what could have been a nice up day

1 · Reply

DARKP00L Oct. 1 at 6:08 PM

$DOCS 13:36 on Oct. 01 2025 Goldman Sachs Downgrades Doximity to Sell, Raises Price Target to $64 #tradeideas

0 · Reply

JarvisFlow Oct. 1 at 5:36 PM

Goldman Sachs has adjusted their stance on Doximity ( $DOCS ), setting the rating to Sell with a target price of 57 → 64.

0 · Reply

notreload_ai Oct. 1 at 11:13 AM

Goldman Sachs downgraded $DOCS to Sell from Neutral, setting a price target of $64, indicating a 13% downside potential due to slowing growth.

1 · Reply

dailyslapz Sep. 30 at 7:43 PM

$DOCS shitty politicians are buying this. Might be a buy

0 · Reply

lasoto3 Sep. 29 at 2:48 PM

$DOCS hit my goal here. Out for now

0 · Reply

SweepCastApp Sep. 29 at 12:38 PM

$DOCS: Unusual Options Activity Alerted CALL flow observed 100x contracts at Strike price of $100 Exp on 02/20/2026 with Premium of $34K and showing NEUTRAL Sentiment

0 · Reply

MoneyGroupLLC Sep. 29 at 6:41 AM

Enter: $DOCS NOV 21 2025 $75 CALLS Buy in Price: $6.57 - $6.70 Take Profit: $12.02 Stop Bleeding: $5.78 ROI Potential: 83% Exit Within: 140 Minutes https://moneygroup.us/alerts

0 · Reply

WallStreetBuyDip Sep. 28 at 11:55 PM

$DOCS trading at $74 with below-average volume, while $TDOC priced at $8 with above-average volume. DOCS showing relative strength, but TDOC's volume suggests more interest. Are investors favoring the lower-priced play in the Telemedicine sector?

0 · Reply

SweepCastApp Sep. 26 at 9:44 PM

$DOCS: SWEEP PUT orders printed 16 @ 16.50 Strike 77.5 Exp 01/15/2027 Premium $26.4K Sentiment BULLISH

0 · Reply

ZacksResearch Sep. 26 at 5:33 PM

Hims & Hers vs. Doximity — which is the better buy now? 🤔 $HIMS, up 208.8% over the past year, focuses on affordability and consumer access, while $DOCS, up 73.4%, leverages its physician network. Despite both trading above sector averages, HIMS is less expensive and offers a compelling growth story with its international expansion and AI-driven initiatives. Discover why Hims & Hers might be the more stable investment 👉 https://www.zacks.com/stock/news/2757763/hims-vs-docs-which-digital-health-platform-is-a-better-investment?cid=sm-stocktwits-2-2757763-body-14364&ADID=SYND_STOCKTWITS_TWEET_2_2757763_BODY_14364

0 · Reply

howardlindzon Sep. 26 at 5:08 PM

$DOCS chat gpt for doctors...lots of lawsuits in thsi space from the big venture capitalists...winner likely takes all i will look to chat with executives

0 · Reply

ZacksResearch Sep. 26 at 4:33 PM

$HIMS vs. $DOCS — who’s the real digital health winner? Both are reshaping the space, but the edge comes down to earnings growth and platform expansion. See the full head-to-head breakdown here 👉 https://www.zacks.com/stock/news/2757763/hims-vs-docs-which-digital-health-platform-is-a-better-investment?cid=sm-stocktwits-2-2757763-teaser-14355&ADID=SYND_STOCKTWITS_TWEET_2_2757763_TEASER_14355

0 · Reply

howardlindzon Sep. 26 at 3:41 PM

$DOCS doing some research...great looking biz

1 · Reply

SweepCastApp Sep. 26 at 10:40 AM

$DOCS: SWEEP PUT activity detected 36 @ 15.30, Strike 75.0, Exp 1/15/2027, Premium $55,080, Sentiment BULLISH

0 · Reply

popme Sep. 26 at 12:00 AM

$DOCS news out 100 % tarifs to patent drugs ! Big pharma will stop advertising them until this is clear! Docs get 80 % of income from advertisement!

0 · Reply

Market Cap	13.72B
Revenue (ttm)	570.40M
Net Income (ttm)	223.19M
EPS (ttm)	N/A
PE Ratio	59.99
Forward PE	64.52
Profit Margin	39.13%
Debt to Equity Ratio	0.00

Volume	1,009,685
Avg Vol	1,563,248
Day's Range	N/A - N/A
Shares Out	187.30M
Stochastic %K	49%
Beta	1.38
Analysts	Sell
Price Target	$69.22